Peritonitis due toMycobacterium mucogenicumin an end-stage renal failure patient undergoing peritoneal dialysis

Noralia Nordin , Nor Azlina Ahmad , Fairuz Ridzlan A. Rashid , Nur Diyanah Binti Mohd Salim , Nor Izzah Mazan

Asian Pacific Journal of Tropical Medicine ›› 2026, Vol. 19 ›› Issue (3) : 143 -144.

PDF (398KB)
Asian Pacific Journal of Tropical Medicine ›› 2026, Vol. 19 ›› Issue (3) :143 -144. DOI: 10.4103/apjtm.apjtm_577_25
Letter to Editor
research-article
Peritonitis due toMycobacterium mucogenicumin an end-stage renal failure patient undergoing peritoneal dialysis
Author information +
History +
PDF (398KB)

Cite this article

Download citation ▾
Noralia Nordin, Nor Azlina Ahmad, Fairuz Ridzlan A. Rashid, Nur Diyanah Binti Mohd Salim, Nor Izzah Mazan. Peritonitis due toMycobacterium mucogenicumin an end-stage renal failure patient undergoing peritoneal dialysis. Asian Pacific Journal of Tropical Medicine, 2026, 19 (3) : 143-144 DOI:10.4103/apjtm.apjtm_577_25

登录浏览全文

4963

注册一个新账户 忘记密码

Conflict of interest statement

The author(s) declared no potential conflicts of interest concerning the research, authorship, and/or publication of this article.

Informed consent to publish

Written informed consent was obtained from the patient for the anonymised information to be published in this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Authors’ contributions

NN: Conceptualization, wrote the first draft of the manuscript. NAA, FRAR, NDMS: Writing-review & editing. NIM: Supervision. All authors reviewed and approved the final version of the manuscript.

Publisher’s note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by Pan Y, Lei Y, Zhang Q

Acknowledgments

We would like to thank the Director General of Health Malaysia for his permission to publish this article (NMRR ID-25-01335-PIE).

References

[1]

El Helou G, Hachem R, Viola GM, El Zakhem A, Chaftari AM, Jiang Y, et al. Management of rapidly growing mycobacterial bacteremia in cancer patients. Clin Infect Dis 2013; 56: 843-846.

[2]

Adékambi T. Mycobacterium mucogenicum group infections: A review. Clin Microbiol Infect 2009; 15: 911-918.

[3]

Conville PS, Witebsky FG. Lack of usefulness of carbon utilization tests for identification of Mycobacterium mucogenicum. J Clin Microbiol 2001; 39: 2725-2728.

[4]

Adékambi T, Drancourt M. Dissection of phylogenetic relationships among 19 rapidly growing Mycobacterium species by 16S rRNA, hsp65, sodA, recA and rpoB gene sequencing. Int J Syst Evol Microbiol 2004; 54: 2095-2105.

[5]

Huang WC, Yu MC, Huang YW. Identification and drug susceptibility testing for nontuberculous mycobacteria. J Formos Med Assoc 2020; 119: S32-S41.

[6]

Pradier M, Boucher A, Robineau O, Chachaty E, Meybeck A, Senneville E. Mycobacterium mucogenicum bacteremia: Major role of clinical microbiologists. BMC Infect Dis 2018; 18: 3-5.

PDF (398KB)

22

Accesses

0

Citation

Detail

Sections
Recommended

/